Somewhat Positive Press Coverage Somewhat Unlikely to Affect Healthequity (NASDAQ:HQY) Share Price

Media headlines about Healthequity (NASDAQ:HQY) have trended somewhat positive this week, according to Accern Sentiment Analysis. Accern scores the sentiment of press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Healthequity earned a media sentiment score of 0.19 on Accern’s scale. Accern also assigned media stories about the company an impact score of 45.1367849011795 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Healthequity (HQY) opened at $48.40 on Friday. Healthequity has a 1-year low of $37.62 and a 1-year high of $55.31. The stock has a market capitalization of $2,940.00, a price-to-earnings ratio of 65.41, a P/E/G ratio of 1.98 and a beta of 1.74.

Healthequity (NASDAQ:HQY) last posted its quarterly earnings data on Tuesday, December 5th. The company reported $0.17 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.13 by $0.04. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. The company had revenue of $56.80 million during the quarter, compared to analysts’ expectations of $55.27 million. During the same quarter in the previous year, the business earned $0.10 EPS. Healthequity’s revenue was up 31.0% compared to the same quarter last year. analysts forecast that Healthequity will post 0.71 earnings per share for the current year.

Several research analysts have issued reports on the company. Chardan Capital raised their price objective on Healthequity from $58.00 to $62.00 and gave the stock a “buy” rating in a research note on Wednesday, December 6th. Zacks Investment Research raised Healthequity from a “hold” rating to a “buy” rating and set a $60.00 target price on the stock in a research note on Wednesday, November 8th. BidaskClub raised Healthequity from a “sell” rating to a “hold” rating in a research note on Tuesday, November 7th. Cantor Fitzgerald reissued a “buy” rating and set a $56.00 target price on shares of Healthequity in a research note on Monday, September 25th. Finally, Robert W. Baird restated a “hold” rating on shares of Healthequity in a report on Thursday, September 21st. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $58.33.

In related news, EVP Delano Ladd sold 26,405 shares of the company’s stock in a transaction dated Tuesday, December 12th. The stock was sold at an average price of $43.32, for a total transaction of $1,143,864.60. Following the transaction, the executive vice president now directly owns 16,692 shares of the company’s stock, valued at approximately $723,097.44. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, VP Darcy G. Mott sold 9,500 shares of the company’s stock in a transaction dated Monday, November 20th. The shares were sold at an average price of $49.68, for a total value of $471,960.00. Following the transaction, the vice president now directly owns 93,500 shares in the company, valued at $4,645,080. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 1,106,934 shares of company stock valued at $57,943,828. 29.00% of the stock is owned by company insiders.

ILLEGAL ACTIVITY NOTICE: “Somewhat Positive Press Coverage Somewhat Unlikely to Affect Healthequity (NASDAQ:HQY) Share Price” was posted by Week Herald and is owned by of Week Herald. If you are viewing this report on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The original version of this report can be accessed at https://weekherald.com/2018/01/19/somewhat-favorable-news-coverage-somewhat-unlikely-to-impact-healthequity-hqy-stock-price.html.

Healthequity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Insider Buying and Selling by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply